1. Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma
   ZHONG-PING MAO et al, 2015, Oncology Letters CrossRef
2. Expression and clinical significance of glucose transporter-1 in pancreatic cancer
   KAI LU et al, 2016, Oncology Letters CrossRef
3. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma
   Yuichiro Kubo et al, 2014, Human Pathology CrossRef
4. Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
   Angara Zambrano et al, 2019, International Journal of Molecular Sciences CrossRef
5. Expression of glucose transporters in cancers
   Leszek Szablewski, 2013, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
6. Smart nanocarriers in glucose transporters-targeted delivery of anticancer drugs
   Sanaz Dastghaib et al, 2020, Smart Nanocontainers CrossRef
7. Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
   Hiroshi Sawayama et al, 2019, Cancer Science CrossRef
8. Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness
   Sofia Cotton et al, 2021, International Journal of Molecular Sciences CrossRef
9. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells
   XIAO-HONG CHEN et al, 2013, Molecular Medicine Reports CrossRef
10. Depth of invasion and GLUT-1 as risk predictors in oral squamous cell carcinoma
    Sindhu M Ganvir et al, 2017, Translational Research in Oral Oncology CrossRef
11. Clinical and Prognostic Impact of the Warburg Effect in Esophageal Carcinoma: Monocarboxylate Transporters as Candidates for Therapeutic Targeting
    Julieta Afonso et al, 2023, Pathobiology CrossRef
12. Prognostic impact of the combination of HIF‑1α and GLUT1 in patients with oesophageal squamous cell carcinoma
    Hanjie Yi et al, 2023, Oncology Letters CrossRef
13. Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
    Marek Samec et al, 2021, Cancers CrossRef
14. Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis
    Zheng-Xiao Zhao et al, 2018, Oncotarget CrossRef
15. Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review
    Jurgen Peerlings et al, 2017, Methods CrossRef
16. Impact of retention index on the neoadjuvant chemotherapy effect and the prognosis in oesophageal cancer
    Keita Kouzu et al, 2023, Japanese Journal of Clinical Oncology CrossRef